scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.ATV.14.2.265 |
P698 | PubMed publication ID | 8305419 |
P2093 | author name string | H Kato | |
T Miyata | |||
T Matsuo | |||
T Sakata | |||
K Kario | |||
P433 | issue | 2 | |
P304 | page(s) | 265-274 | |
P577 | publication date | 1994-02-01 | |
P1433 | published in | Arteriosclerosis and thrombosis : a journal of vascular biology | Q27709770 |
P1476 | title | Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese | |
P478 | volume | 14 |
Q44518845 | Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia |
Q41823356 | Computational investigation of potential dosing schedules for a switch of medication from warfarin to rivaroxaban-an oral, direct Factor Xa inhibitor. |
Q44045719 | Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease |
Q38757815 | Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study. |
Q72664696 | Factor VII hyperactivity and ischaemic heart disease |
Q73165312 | Heparin lowers plasma levels of activated factor VII |
Q43687646 | High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage |
Q28360273 | Is activated factor VII associated with retinal vein occlusion? |
Q50947214 | Measurement of factor VII and of activated factor VII in healthy individuals and in prothrombin complex concentrates |
Q41047270 | Pathophysiology and inflammatory aspects of plaque rupture |
Q73128607 | Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction |
Q73378387 | Reduction of factor FVIIa activity during heparin therapy. Evidence for assay interactions with tissue factor pathway inhibitor and antithrombin |
Q53815642 | Role of coagulation factor VII in pathogenesis of ischemic heart disease. |
Q42832220 | The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-α or isoproterenol. |
Q73353249 | [Coagulant activity of factor VII (FVIIc) in the elderly with ischemic heart disease] |
Search more.